ANI
About
What does ANI do?
ANI Pharmaceuticals, Inc. is a diversified biopharmaceutical company committed to developing, manufacturing, and commercializing innovative and high-quality therapeutics. They are transforming into a leading Rare Disease company, with a focus on ophthalmology, rheumatology, nephrology, neurology, and pulmonology, alongside a strong Generics business leveraging R&D expertise and U.S.-based manufacturing.
What is ANI's valuation?
StartupHub estimates ANI's effective valuation at $15.1B (range $8.6B to $20.6B, 19% confidence), based on comparable companies in the sector.
How much funding has ANI raised?
ANI has raised a total of $3.4B in funding. The most recent round on record is Seed.
Where is ANI headquartered?
ANI is headquartered in Princeton, United States.
When was ANI founded?
ANI was founded in 1981.
What industry does ANI operate in?
ANI operates in Biopharmaceutical, Rare Disease, Ophthalmology, Generics, Drug Discovery, Manufacturing.
How many employees does ANI have?
ANI has approximately 710 people on record.
No comments yet. Be the first to share your take.